Agonist/endogenous peptide–MHC heterodimers drive T cell activation and sensitivity

Michelle Krogsgaard(Eastern Cooperative Oncology Group), Mark M. Davis(Stanford Medicine), Johannes B. Huppa(Howard Hughes Medical Institute), Qijing Li(Sichuan University), Morgan Huse(Memorial Sloan Kettering Cancer Center), Cenk Sumen(Harvard University)
Nature
February 20, 2005
Cited by 343


Related Papers